Journal
HEPATOLOGY
Volume 64, Issue 4, Pages 1217-1231Publisher
WILEY
DOI: 10.1002/hep.28723
Keywords
-
Categories
Funding
- German Cancer Aid (Deutsche Krebshilfe) [110043]
- German Research Foundation [LU 1360/3-1, SFB-TRR57/P06, SFB-TR36, LU 466/16-1]
- ERC [ERC-2007-Stg / 208237-Luedde-Med3-Aachen]
- EMBO Young Investigator Program
- Interdisciplinary Center for Clinical Research (IZKF) Aachen, Germany
- Ernst-Jung-Foundation Hamburg
- medical faculty of the RWTH Aachen
- Helmholtz Foundation
- Hofschneider Foundation
- Helmholtz Alliance PCCC
- Deutsche Stiftung Herzforschung [12/12]
- NIH [R01 AI043477]
Ask authors/readers for more resources
The I kappa B-Kinase (IKK) complex-consisting of the catalytic subunits, IKK alpha and IKK beta, as well as the regulatory subunit, NEMO-mediates activation of the nuclear factor kappa B (NF-kappa B) pathway, but previous studies suggested the existence of NF-kappa B-independent functions of IKK subunits with potential impact on liver physiology and disease. Programmed cell death is a crucial factor in the progression of liver diseases, and receptor-interacting kinases (RIPKs) exerts strategic control over multiple pathways involved in regulating novel programmed cell-death pathways and inflammation. We hypothesized that RIPKs might be unrecognized targets of the catalytic IKK-complex subunits, thereby regulating hepatocarcinogenesis and cholestasis. In this present study, mice with specific genetic inhibition of catalytic IKK activity in liver parenchymal cells (LPCs; IKK alpha/beta(LPC-KO)) were intercrossed with RIPK1(LPC-KO) or RIPK3(-/-) mice to examine whether RIPK1 or RIPK3 might be downstream targets of IKKs. Moreover, we performed in vivo phospho-proteome analyses and in vitro kinase assays, mass spectrometry, and mutagenesis experiments. These analyses revealed that IKKa and IKK beta-in addition to their known function in NF-kappa B activation-directly phosphorylate RIPK1 at distinct regions of the protein, thereby regulating cell viability. Loss of this IKK alpha/beta-dependent RIPK1 phosphorylation in LPCs inhibits compensatory proliferation of hepatocytes and intrahepatic biliary cells, thus impeding HCC development, but promoting biliary cell paucity and lethal cholestasis. Conclusions: IKK-complex subunits transmit a previously unrecognized signal through RIPK1, which is fundamental for the long-term consequences of chronic hepatic inflammation and might have potential implications for future pharmacological strategies against cholestatic liver disease and cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available